Found 12 matching trials
Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination. PHASE3 RSV (which stands for Respiratory Syncytial Virus) is an infection that cau...
Show More Location
Multiple Locations
Learn More & Join Trial
Vaccination Response Modulation With a Targeted Rapamycin Protocol Study PHASE2 This study will investigate dialysis recipients' responses to important vac...
Show More Location
Royal Prince Alfred Hospital
Learn More & Join Trial
STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON) N/A This Pfizer-sponsored real-world retrospective non-interventional study wil...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset N/A This study will use a retrospective cohort design and will be conducted wit...
Show More Location
Multiple Locations
Learn More & Join Trial
Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV in Children Under 6 Months in Bogotá N/A This study aims to evaluate the real-world effectiveness of two preventive ...
Show More Status
Active Not Recruiting
Location
Secretaria distrital de Salud
Learn More & Join Trial
Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy N/A This study will be conducted in collaboration with a research network of in...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults PHASE4 The purpose of this pragmatic randomized trial is to evaluate the vaccine e...
Show More Status
Active Not Recruiting
Location
Center for Translational Cardiology and Pragmatic Randomized Trials Department of Cardiology Copenhagen University Hospital - Herlev and Gentofte
Learn More & Join Trial
The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products PHASE4 Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory...
Show More Location
Emory University School of Medicine
Learn More & Join Trial
Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania N/A Globally, respiratory syncytial virus (RSV) is the leading cause of lower r...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination PHASE3 RSV (which stands for Respiratory Syncytial Virus) is an infection that cau...
Show More Learn More & Join Trial